Premium
Activating point mutation in Ki‐ ras codon 63 in a chemically induced rat renal tumor
Author(s) -
Higinbotham Kathleen G.,
Rice Jerry M.,
Perantoni Alan O.
Publication year - 1992
Publication title -
molecular carcinogenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.254
H-Index - 97
eISSN - 1098-2744
pISSN - 0899-1987
DOI - 10.1002/mc.2940050209
Subject(s) - biology , point mutation , microbiology and biotechnology , mutation , transfection , start codon , exon , transition (genetics) , genetics , gene , messenger rna
Renal mesenchymal tumors induced in F344 rats with methyl(methoxymethyl)nitrosamine (DMN‐OMe) have previously been shown by our laboratory to contain transforming Ki‐ ras sequences, activated most commonly by a variety of codon 12 mutations. Further sequence analysis of one DMN‐OMe‐induced tumor with transforming Ki‐ ras sequences detected by NIH 3T3 transfection assay but with no mutation in codon 12 detected by selective oligonucleotide hybridization has now revealed an activating point mutation in codon 63. The observed GAG→AAG transition in codon 63, which replaces glutamic acid with lysine, was the only detectable mutation in exon 1 and 2 hotspot regions of Ki‐ ras in this tumor. The same mutation was also detected in Ki‐ ras sequences derived from first‐ and second‐cycle transformants in NIH 3T3 transfection assays. Although random mutagene‐sis studies of cloned Ha‐ ras sequences by Fasano et al. (Proc Natl Acad Sci USA 81:4008–4012, 1984) had already indicated that GAG→AAG mutations in codon 63 of ras are transforming, this is the first demonstration of the natural occurrence of this particular activating mutation in a tumor. © 1992 wiley‐List, Inc.